{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:07:56Z","timestamp":1778843276317,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Not all medications arrive from a disciplined path of translational drug development; sometimes, the route of discovery involves serendipity. A drug developed for controlling urinary urgency, oxybutynin, is reviewed here as a highly effective treatment for excessive sweating (hyperhidrosis). Its use in Parkinson disease is described in a case report.<\/jats:p>","DOI":"10.1177\/1877718x261440704","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:14:47Z","timestamp":1775556887000},"page":"609-611","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Oxybutynin treatment for episodic hyperhidrosis in Parkinson disease"],"prefix":"10.1177","volume":"16","author":[{"given":"Peter A.","family":"LeWitt","sequence":"first","affiliation":[{"name":"From the Departments of Neurology and Pharmacology, and the Sastry Foundation Endowed Chair in Parkinson Disease Research, Wayne State University School of Medicine, Detroit, Michigan USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.3.506-a"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831020-00002"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10586"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21006"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1345307"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18072"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370124"},{"key":"e_1_3_2_9_2","first-page":"900","article-title":"Nonmotor fluctuations in Parkinson\u2019s disease: severity and correlation with motor complications","volume":"80","author":"Storch A","year":"2003","unstructured":"Storch A, Schneider CB, Wolz M, et al. Nonmotor fluctuations in Parkinson\u2019s disease: severity and correlation with motor complications. Neurology 2003; 80: 900\u2013809.","journal-title":"Neurology"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2307\/1411377"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09325-w"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.1125"},{"key":"e_1_3_2_13_2","first-page":"523","article-title":"Management of primary focal hyperhidrosis: an algorithmic approach","volume":"20","author":"Liu V","year":"2021","unstructured":"Liu V, Farshchian M, Potts GA. Management of primary focal hyperhidrosis: an algorithmic approach. J Drugs Dermatol 2021; 20: 523\u2013528.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.9.1122"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000371581"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14832"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2012.16.3.107"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000049903.60057.4b"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00504-x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7119.1363"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2892"},{"key":"e_1_3_2_22_2","article-title":"Oxybutynin induced hyperthermia in a patient with Parkinson\u2019s disease","volume":"13","author":"Ahmad S","year":"2021","unstructured":"Ahmad S, Reyes JVM, Lieber J. Oxybutynin induced hyperthermia in a patient with Parkinson\u2019s disease. Cureus 2021; 13: e14701.","journal-title":"Cureus"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261440704","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261440704","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261440704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:17:44Z","timestamp":1778840264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261440704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/1877718X261440704"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261440704","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}